Recalls & Warnings June 25, 2019 Kratom Is Dangerous and Not Proven to Treat Addiction, FDA Warns Marketers On June 25, 2019, the FDA issued warning letter to two marketers and distributors of kratom products, listed below, for illegally selling unapproved, misbranded kratom-containing drug products with unproven claims about their ability to treat or cure opioid addiction and withdrawal symptoms
CagriSema is composed of the GLP-1 RA semaglutide and the long-acting insulin analog cagrilintide, and can be administered subcutaneously once a week
I love when patients have unexpected benefits from glutathione it can be truly life changing for some
Because standard GLP-1s control appetite but can cause metabolic adaptation, providers often introduce a secondary compound like 5-Amino-1MQ or Tesofensine to keep the metabolic rate elevated
These options help you feel as good as you look, promoting a holistic sense of well-being
[5] [6] It is also used in combination with 5-fluorouracil to treat colorectal cancer and pancreatic cancer, and may be used to treat folate deficiency, anemia, and methanol poisoning